Management of Neonates Born to Mothers with Group B Streptococcus Colonization

Journal of Perinatology

Volumn 16, Issue 6, 1996, Pages 470-477

  Alkalay, Arie L ^a,b   Brunell, Philip A ^a   Greenspon, Jeffrey S ^a   Pomerance, Jeffrey J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CHEMOPROPHYLAXIS; DISEASE TRANSMISSION; FEMALE; HUMAN; MICROBIOLOGY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION;

ALGORITHMS; CHEMOPREVENTION; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0030279807     PISSN: 07438346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics 1992;90:775-8.
2. Teres FO, Matorras R, Perea AG, et al. Prevention of neonatal group B streptococcal sepsis. Infect Dis 1987;6:874.
3. Pylipow M, Gaddis M, Kinney JS. Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. Pediatrics 1994;93:631-5.
4. Cochi SL, Feldman RA. Estimating national incidence of group B streptococcal disease: the effect of adjusting for birth weight. Pediatr Infect Dis 1983;2:414-5.
5. Boyer KM, Gadzala CA, Burd LI, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis 1983;148:795-801.
6. Zangwill KM, Schuchat A, Wenger JD. Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. In: CDC surveillance summaries. MMWR 1992;41:25-32.
7. Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infant. In: Baker CJ, Edwards MS. Group B streptococcal infection. Fourth ed. Philadelphia: WB Saunders, 1995:980-1054.
8. Baker CJ, Edwards MS. Group B streptococcal infections: perinatal impact and prevention methods. Ann N Y Acad Sci 1988;549:193-202.
9. Anthony BF, Eisenstadt RT, Carter J, et al. Genital and intestinal carriage of group B streptococci during pregnancy. J Infect Dis 1981;143:761-6.
10. Thompsen AC, Morup CL, Hansen KB. Antibiotic elimination of group-B streptococci in the urine in prevention of preterm labor. Lancet 1987;1:591-3.
11. Boyer KM, Gadzala CA, Kelly PD, et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease: II - predictive value of prenatal culture. J Infect Dis 1983;148:802-9.
12. Regan JA, Klebanoff MA, Nugent RP, and the Vaginal Infection and Prematurity Study Group. The epidemiology of group B streptococcal colonization in pregnancy. Obstet Gynecol 1991;77:604-10.
13. Gardner SE, Yow MD, Leeds LJ, et al. Failure of penicillin to eradicate group B streptococcal colonization in pregnant women. Am J Obstet Gynecol 1979;135:1062-5.
14. Baker CJ. Maternal chemoprophylaxis for group B streprococcal sepsis. Pediatr Infect Dis 1991;1:9-10.
15. American College of Obstetricians and Gynecologists. Group B streptococcal infection in pregnancy. Technical Bulletin No. 170, 1992.
16. Department of Health and Human Services, Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR 1996;45:1-24
17. Yancey MK, Armer T, Clark P, et al. Assessment of rapid identification tests for genital carriage of group B streptococci. Obstet Gynecol 1992;30:1038-47.
18. McDuffie RSJr, McGregor JA, Gibbs RS. Adverse perinatal outcome and resistant enterobacteriaceae after antibiotic usage for premature rupture of the membranes and group B streptococcal carriage. Obstet Gynecol 1993;82:487-9.
19. Bray RE, Boe RW, Johnson WL. Transfer of ampicillin into fetus and amniotic fluid from maternal plasma late in pregnancy. Am J Obstet Gynecol 1966;96:933-42.
20. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum prophylaxis. N Engl J Med 1986;314:1665-9.
21. Schuchat A, Oxtoby M, Cochi S, et al. Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-7.
22. Rouse DJ, Goldberg RL, Cliver SP, et al. Strategies for prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 1994;83:483-94.
23. Katz VL, Moose MK, Cefalo RC, et al. Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment. Am J Obstet Gynecol 1994;170:521-6.
24. Allen UD, Navas L, King SM. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: results of metaanalysis. Can Med Assoc J 1993;149:1659-65.
25. Gibbs RS, Hall RT, Yow MD, et al. Consensus perinatal prophylaxis for group B streptococcal infection. Pediatr Infect Dis J 1992;11:179-83.
26. Pyati SP, Pildes RS, Jacobs NM, et al. Penicillin in infants weighing two kilograms or less with early-onset group B streptococcal disease. N Engl J Med 1983;308:1383-8.
27. Schuchat A, Oxtoby M, Cochi S, et al. Population based risk factors for neonatal group B streptococcal disease: results of a chohort study in metropolitan Atlanta. J Infect Dis 1990;162:672-7.
28. Schuchat A, Deaver-Robinson K, Plikaytis RD, et al. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J 1994;13:623-9.
29. Persson K, Christensen KK, Christensen P, et al. Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scan J Infect Dis 1985;17:195-9
30. Benitz WE, Tatro DS, eds. The pediatric drug handbook. 2nd ed. Chicago: Year Book Medical, 1990:505.
31. American Academy of Pediatrics. Red book. 1994:440-41.
32. Nyhan WL, Fousek MD. Septicemia of the newborn. Pediatrics 1958; 22:268-78.
33. Gluck L, Wood HF, Fousek MD. Septicemia of the newborn. Pediatr Clin North Am 1966;13:1131-48.
34. Moorman RS Jr, Sell SH. Neonatal septicemia. South Med J 1961;54: 137-41.
35. Buetow KC, Klein SW, Lane RB. Septicemia in premature infants. Arch Pediatr Adolesc Med 1965;110:29-41.
36. Jeffrey H, Mitchison R, Wigglesworth JJ, et al. Early neonatal bacteremia. Arch Dis Child 1977;52:683-6.
37. Pyne NR, Burke BA, Day DL, et al. Correlation of clinical and pathological findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome. Pediatr Infect Dis J 1988;12:836-47.
38. Manroe BL, Weinberg AG, Rosenfeld CR, et al. The neonatal blood count in health and disease: I - reference values for neutrophilic cells. J Pediatr 1979;95:89-98.
39. Mouzinho A, Rosenfeld CR, Sanchez PJ, Risser R. Revised reference ranges for circulating neutrophils in very-low-birth-weight infants. Pediatrics 1994;94:76-82.
40. Schelonka RL, Yoder BA, deJardins SE, et al. Peripheral leukocyte count and leukocyte index in healthy newborn term infants. J Pediatr 1994; 125:603-6.
41. Schelonka RL, Bradely A, Yoder BA, et al. Are segmented and band neutrophils reliably differentiated in the early newborn period? Pediatr Res 1955;37:285A.
42. Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. In: Powell KR, Marcy SM. Laboratory aids for diagnosis of neonatal sepsis. 4th ed. Philadelphia: WB Saunders, 1995:1223-40.
43. Barak M, Cohen A, Herschkowitz S. Total leukocyte and neutrophil count changes associated with antenatal betamethasone administration in premature infants. Acta Paediatr 1992;81:760-3.
44. Herson VC, Block C, Eisenfeld LI, et al. Effect of labor and delivery on neonatal polymorphonuclear leukocyte number and function. Am J Perinatol 1992;9:285-8.
45. Lee LA, Weston WL. New findings in neonatal lupus syndrome. Arch Pediatr Adolesc Med 1984;138:233-6.
46. Davies PA, Gothefors LA, eds. Bacterial infections in the fetus and newborn infant. In: Diagnostic procedures. Philadelphia: WB Saunders, 1984:81.
47. Lloyd BW, Oto A. Normal values of mature and immature neutrophils in very preterm babies. Arch Dis Child 1982;57:233-5.
48. Greenberg DN, Yoder BA. Changes in the differential white blood cell count in screening for group B streptococcal infection. Pediatr Infect Dis J 1990;9:886-9.
49. Sarff LD, Platt LH, McCrackrn Jr GH. Cerebrospinal fluid evaluation in neonates: comparison of high-risk infants with and without meningitis. J Pediatr 1976;88:473-7.
50. Shankarah S, Farook ZQ, DeSai R. Beta-hemolytic streptococcal infection appearing as persistent fetal circulation. Arch Pediatr Adolesc Med 1982;136:725-7.
51. Wiswell TE, Stoll BJ, Tuggle JM. Management of asymptomatic, term gestation neonates born to mothers treated with intrapartum antibiotics. Pediatr Infect Dis J 1990;11:826-31.
52. Sanchez PJ, Siegel LD, Cushion NB, et al. Significance of a positive urine group B streptococcal agglutination test in neonates. J Pediatr 1990; 116:601-6.
53. Ascher DP, Wilson S, Mendiola J, et al. Group B streptococcal latex agglutination testing in neonates. J Pediatr 1991;119:458-61.
54. Zuerlein TJ, Christensen B, Hall RT, et al. Latex agglutination detection of group B streptococcal inoculum in urine. Diagn Microbiol Infect Dis 1991;14:191-4.